The Division of Anesthesiology, Soraka Medical Center and Ben Gurion University of the Negev, Beer-Sheva, Israel.
Exp Neurol. 2010 Aug;224(2):465-71. doi: 10.1016/j.expneurol.2010.05.009. Epub 2010 May 21.
Isoflurane-anesthetized rats submitted to a closed head injury (CHI) display a significant decrease of their blood glutamate levels. Having demonstrated that a decrease of blood L-glutamate (glutamate) causes an increase of the driving force for a spontaneous brain-to-blood glutamate efflux, and consequently affords brain neuroprotection, we investigated here the possible mechanisms which can affect blood glutamate levels. Reasoning that the spontaneous decrease of blood glutamate levels post CHI could be part of a stress response, we observed that the stress involved in tail artery catheterization under isoflurane anesthesia does not affect blood glutamate levels. Investigating in naïve rats the stress effectors, we found that corticotropin-releasing factor (CRF) significantly decreased blood glutamate levels. Pretreatment with antalarmine (a selective type-1 CRF receptor antagonist) occludes the CRF-mediated decrease in blood glutamate levels. In contrast, the adrenocorticotrophic hormone (ACTH) did not affect blood glutamate levels. Investigating the effectors of the sympathetic/adrenomedullary system, we observed that in naïve rats, adrenaline but not noradrenaline decreased blood glutamate levels. Confirming the role of adrenaline, propranolol pretreatment (a non-selective beta-antagonist) prevented the spontaneous decrease of blood glutamate observed post CHI. On the strength of these results, we further observed that isoproterenol (a beta(1/2)-selective adrenoreceptor agonist) produced a marked sustained decrease in blood glutamate levels. These results suggest that stress induces a decrease of blood glutamate levels partly via the activation of peripheral CRF receptors and the activation of the beta-adrenoreceptors. We propose that this newly identified component of the stress response could be a peripherally mediated defense mechanism of the injured brain against the deleterious effects of excess glutamate.
异氟烷麻醉大鼠颅脑闭合性损伤(CHI)后,其血液谷氨酸水平显著降低。我们已经证明,血液 L-谷氨酸(谷氨酸)水平降低会增加脑向血液谷氨酸外排的驱动力,从而提供脑保护,因此我们在此研究了可能影响血液谷氨酸水平的机制。我们推断,CHI 后血液谷氨酸水平的自发降低可能是应激反应的一部分,因此观察到异氟烷麻醉下尾动脉导管插入术引起的应激不会影响血液谷氨酸水平。在未受伤的大鼠中研究应激效应器,我们发现促肾上腺皮质释放因子(CRF)显著降低了血液谷氨酸水平。预先用antalarmine(一种选择性 1 型 CRF 受体拮抗剂)处理可阻断 CRF 介导的血液谷氨酸水平降低。相反,促肾上腺皮质激素(ACTH)不影响血液谷氨酸水平。研究交感神经/肾上腺髓质系统的效应器,我们观察到在未受伤的大鼠中,肾上腺素而不是去甲肾上腺素降低了血液谷氨酸水平。证实了肾上腺素的作用,普萘洛尔预处理(一种非选择性β-拮抗剂)阻止了 CHI 后观察到的血液谷氨酸的自发降低。基于这些结果,我们进一步观察到,异丙肾上腺素(一种β1/2-选择性肾上腺素受体激动剂)可显著持续降低血液谷氨酸水平。这些结果表明,应激通过激活外周 CRF 受体和激活β-肾上腺素受体引起血液谷氨酸水平降低。我们提出,这种新发现的应激反应成分可能是受伤大脑针对过量谷氨酸的有害影响的外周介导的防御机制。